Post-transplant de novo malignancies in renal transplant recipients: the past and present.
about
Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipientsCancer Metastases: Early Dissemination and Late RecurrencesSafety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant RecipientsImmune phenotype predicts risk for posttransplantation squamous cell carcinoma.Targeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus.Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) CohortChanging donor source pattern for kidney transplantation over 40 years: a single-center experienceCyclosporin A promotes tumor angiogenesis in a calcineurin-independent manner by increasing mitochondrial reactive oxygen species.Treatment of advanced rectal cancer after renal transplantation.Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centreClinical characteristics and treatment outcomes of colorectal cancer in renal transplant recipients in Korea.CTLA4 polymorphisms and de novo malignancy risk after renal transplantation in Chinese recipients.Incidence and clinicopathologic behavior of uterine cervical carcinoma in renal transplant recipientsEarly diagnosis and treatment of breast cancer in Japanese kidney transplant recipients: a single center experienceEndometrial polyps in female allograft recipients with abnormal bleedings.Increased risk of post-transplant malignancy and mortality in transplant tourists: a nationwide population-based cohort study in Taiwan.Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage.Rapamycin affects early fracture healing in mice.Transitional cell carcinoma of the kidney graft: an extremely uncommon presentation of tumor in renal transplant recipients.Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients.The development of squamous cell carcinoma in a patient after kidney transplantation: a case report.Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy.Icotinib combined with rapamycin in a renal transplant recipient with epidermal growth factor receptor-mutated non-small cell lung cancer: A case report.Risk of bladder cancer in renal transplant recipients: a meta-analysis.Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions.Establishing the carcinogenic risk of immunomodulatory drugs.Long-term outcome after liver transplantation.Antineoplastic effects of mammalian target of rapamycine inhibitors.Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD.Malignancies after kidney transplantation: a 40-year single-center experience in Korea.Comparison of patient outcome according to renal replacement modality after renal allograft failure.Validation of the cell line LS180 as a model for study of the gastrointestinal toxicity of mycophenolic acid.Prostate cancer in renal transplant recipients.Immunosuppression with mammalian target of rapamycin inhibitor and incidence of post-transplant cancer in kidney transplant recipients.Posttransplant lymphoproliferative disease presenting as jejunal perforation.Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study.HLA and Risk of Diffuse Large B cell Lymphoma After Solid Organ Transplantation.Reductions in immunosuppression after haematological or solid organ cancer diagnosis in kidney transplant recipients.The correlation between renal transplantation and liver carcinoma: a meta-analysis.
P2860
Q24187213-4E48A598-8399-461F-8FB1-713AAB873563Q26774164-35936A2D-C90D-4842-BF49-E65A131A12C1Q26799916-8FCE815C-2CEC-49B7-A018-29294BE2672FQ33748547-2012F090-0810-4F95-9AEC-EAD225D02094Q33793543-BF2E3C4C-43F2-40F8-8AD9-2FB91F6EADD7Q33880261-6AB26CF2-06BA-405F-8EE3-36BF0A2B9847Q34102124-7AF72020-AB86-4988-A72A-51A661434555Q34518356-8BC13843-954A-4F2A-B1D3-AC0509755A05Q34863512-089C8AE8-3104-4E78-A051-5B3609EA7837Q34959580-02C7D459-5CCA-4B12-8CA2-98F2399C548FQ35003329-A3BFA716-EFA6-4E47-8787-0A37B6A5D2A0Q35033897-46E81921-7405-4512-AACB-B33027C2A4EFQ35150650-78C37326-50D6-4211-B5A2-41B190931374Q35607230-C0F70D09-059C-4BEE-B22F-B2764422E4B2Q35903596-AA206F15-6BA6-47D6-ABE4-9CB123C474B8Q36151709-1D5276A9-A4E3-4FC0-80F2-88EE2C85C531Q36545309-E9BD2E78-2CB2-4CBD-A036-52D6424475A7Q36753578-44A79986-E653-4EEC-8C79-B9D3BD368A7FQ36916059-BE2442DA-ED21-4BFC-B203-58F755E15ECDQ36964382-A15996AB-4CB3-4020-A28C-D0BAE4B3925CQ37007011-087CF1BF-6ED0-4E09-B5A9-6C79432306DAQ37327170-44B46707-FFEE-40F4-BB6A-FBC2BEA997C1Q37348173-BEC258CB-A38D-43B9-AB32-47D1C024AC1EQ37388707-D38EE136-833E-444A-80BA-CDCCC7B9B19FQ37681727-D601D37F-1436-4A98-821C-B33EACAF3682Q37876951-8294037D-1194-49EF-8F14-E7516F0705E9Q37959333-2A92D09C-4AE2-469B-B662-333ABA07EA10Q38002368-FE8B59CE-019F-457D-9EE2-B3BB135503A0Q38156840-C6C9BA4E-6EC8-48BA-A8B0-4AA0574EB6A7Q38253832-C8FDFA7F-AEC2-4643-A26D-714B4E8A0773Q38474214-4CFB141C-6F5D-4F07-BEA5-60169A304115Q38476218-7701A808-FF56-4BDF-B1C3-97F28C6EFDD3Q38704055-2ACAF7E1-021B-4CF9-ACD7-CF5A7AD1C257Q39198216-E9BC0B1D-2AFE-4ED0-8A03-61B8183C6D5BQ39757990-07D14291-7082-41C4-97AA-A91924CCAEFDQ39858442-0488214D-A516-4792-A717-6E479066D880Q40132359-73573FD6-A23A-4618-909F-BEE758BE5952Q40492215-E3969CC7-5AED-4631-9C1E-9B70D188FE99Q40736816-BDDBAD5E-B7CE-4926-AD05-ABC0DC3ADD1CQ41924348-F20BFC2F-67F6-45F6-8838-B82B20E9047F
P2860
Post-transplant de novo malignancies in renal transplant recipients: the past and present.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Post-transplant de novo malign ...... ipients: the past and present.
@ast
Post-transplant de novo malign ...... ipients: the past and present.
@en
type
label
Post-transplant de novo malign ...... ipients: the past and present.
@ast
Post-transplant de novo malign ...... ipients: the past and present.
@en
prefLabel
Post-transplant de novo malign ...... ipients: the past and present.
@ast
Post-transplant de novo malign ...... ipients: the past and present.
@en
P2093
P2860
P1476
Post-transplant de novo malign ...... ipients: the past and present.
@en
P2093
Douglas W Hanto
H Myron Kauffman
Maureen A McBride
Wida S Cherikh
Yulin Cheng
P2860
P304
P356
10.1111/J.1432-2277.2006.00330.X
P577
2006-08-01T00:00:00Z